StockData
ACBMOTCServices-Amusement & Recreation ServicesFiscal year ends December 31

ACRO BIOMEDICAL CO., LTD.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.03+0.00 (0.00%)

Close on Oct 19, 2026

Market cap
$1.56M
P/E (TTM)
–
Dividend yield
–

About Acro Biomedical

Services-Amusement & Recreation Services, SIC 7900

Acro Biomedical Co., Ltd., formerly known as Killer Waves Hawaii, Inc., develops and markets nutritional wellness products centered on cordyceps, a parasitic fungus traditionally utilized in Chinese medicine. Historically, the company has purchased inventory from suppliers in Taiwan to sell in bulk to commercial customers, including distributors. These clients either resell the products directly or incorporate them as ingredients into finished goods. The company has also previously sold metallothionein MT-3 elizer and explored developing cordyceps-based chicken feed, though it does not package or offer items directly for retail consumer use.

The enterprise operates as a Nevada corporation with its corporate office located in Fishers, Indiana. It maintains an extremely limited operational scale, employing a single part-time executive and owning no retail stores, dedicated manufacturing facilities, or intellectual property rights. Its past commercial transactions and customer relationships were centered internationally in Taiwan and Hong Kong, with no historical product sales conducted within the United States.

Summary of the business section of Acro Biomedical's latest annual report, written by StockData.

Company profile

Company

Legal name
ACRO BIOMEDICAL CO., LTD.
Founded
2014
Headquarters
Fishers, IN
Address
12175 Visionary Way, Suite 1160 46038
Phone
(317) 286-6788
Employees
1, Dec 31, 2025
Industry
Services-Amusement & Recreation Services
Incorporated in
Nevada
Fiscal year ends
December 31
Auditor
Weinberg & Company, P.A., Los Angeles, California

Stock & identifiers

Ticker
ACBM
Exchange
OTC
IPO date
Apr 12, 2018
Shares outstanding
60M, Aug 5, 2026
Public float
$21.03K, Jun 30, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company
Stock splits
3-for-1, May 18, 2017
SEC CIK
1622996
EIN
47-1950356

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

No recent ownership filings by officers or directors

Acro Biomedical's leadership is listed in its proxy statement (Form DEF 14A).

Employees

Headcount reported in annual reports

“We have one employee, our chief executive officer and chief financial officer, who works for us on a part-time basis.”

Corporate history

Events identified from SEC filings

DateEventDetails
Jan 8, 2026Auditor changeChange in certifying accountant (8-K Item 4.01)
Jul 2, 2025Auditor changeChange in certifying accountant (8-K Item 4.01)
Nov 15, 2023Late filingNotification of late filing
Apr 3, 2023Late filingNotification of late filing
Nov 14, 2022Late filingNotification of late filing
Apr 1, 2022Late filingNotification of late filing
Nov 16, 2021Late filingNotification of late filing
Aug 17, 2021Late filingNotification of late filing
May 17, 2021Late filingNotification of late filing
Apr 1, 2021Late filingNotification of late filing
Nov 17, 2020Late filingNotification of late filing
Aug 14, 2020Late filingNotification of late filing
May 18, 2020Late filingNotification of late filing
Dec 31, 2019Late filingNotification of late filing
Oct 22, 2018Auditor changeChange in certifying accountant (8-K Item 4.01)
Jul 6, 2018Auditor changeChange in certifying accountant (8-K Item 4.01)
Jun 22, 2018Auditor changeChange in certifying accountant (8-K Item 4.01)
May 16, 2018Late filingNotification of late filing
Dec 29, 2017Late filingNotification of late filing
May 16, 2017Late filingNotification of late filing
May 12, 2017Auditor changeChange in certifying accountant (8-K Item 4.01)
Jan 30, 2017Name changeName changed from KILLER WAVES HAWAII, INC to ACRO BIOMEDICAL CO., LTD.